Crash Course in Cures: Bone Marrow Biopsies in AML Clinical Utility
Bone Marrows biopsies can bring lots of questions and concerns. Hear from Dr.Douglas Tremblay as he discusses the use of bone marrow biopsies in FLT3 Mutant AML.There will be a Q&A session at the end so come with questions!
Eliza introduces the agenda for the event and featured speaker Dr. Douglas Tremblay
Hear from Dr.Douglas Tremblay as he discusses the use of bone marrow biopsies in FLT3 Mutant AML.
Type your questions in the chat and we will answer them!
Eliza Prickett
Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.
Douglas Tremblay, MD
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms. Dr. Tremblay specializes in hematologic malignancies including acute myeloid leukemia, myeloproliferative neoplasms and myelodysplastic syndromes.